Circulating giant macrophages as a potential biomarker of solid tumors
Daniel L. Adams(Creatv MicroTech (United States)), Massimo Cristofanilli(Thomas Jefferson University)
Cited by 278
Related Papers
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
|New England Journal of Medicine|2018|1.3k
The Landscape of Targeted Therapies in TNBC
|Cancers|2020|448
TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients
|Breast Cancer Research|2014|105